Immuno-Oncology vs ALTAI Oncology Usage & Stats

@Point of Care™ with Ask Cognitive AI is a clinical decision-making mobile platform. Immuno-Oncology @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Ask Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. Cognitive AI provides confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Immuno-Oncology @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Immuno-Oncology content • Customize your library with over 50 supplemental topics • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

At Altai Oncology, we recognize the evolving demands of Oncology care. Our new mobile app brings the world of oncology to your fingertips, ensuring you have all the tools necessary for accurate, efficient, and comprehensive patient care. Key Features: Comprehensive Chemotherapy Protocol Library: Explore our extensive collection of over 1,000 meticulously curated protocols since 2015. Each protocol is accompanied by relevant references and clear summaries, keeping you well-informed at all times. Intuitive Calculators: No more manual calculations! Our app includes built-in Body Surface Area (BSA), Body Mass Index (BMI), and Creatinine Clearance calculators, simplifying your daily tasks. Precision Dose Calculation: Ensure patient safety with our dose calculation feature. By merging chosen protocols with specific patient metrics, you receive accurate dosing recommendations every time. Protocol Selection Wizard: Find the perfect protocol with ease. Search our library based on various criteria, from diagnosis and treatment rationale to specific drug inclusions. Up-to-Date Cancer Staging: Accurately stage cancers with Altai’s user-friendly staging module. We’ve integrated the latest TNM staging directly licensed from AJCC, along with other essential scoring systems like IPSS. Whether you’re at the clinic, hospital, or on the move, the Altai Oncology app ensures you’re never without the best oncological resources. We’ve combined years of expertise and technological innovation to deliver an app that’s not only user-friendly but also a game-changer in oncology care. Disclaimer: The Altai Oncology Mobile App is designed to assist medical professionals and individuals with a background in oncology. It is not intended to replace professional medical judgment or diagnosis. Users are encouraged to use their clinical judgment and seek appropriate medical advice when making patient care decisions. Altai Oncology assumes no responsibility or liability for any consequences arising from the use of this app. Join the revolution in Oncology care. Download the Altai Oncology App today! Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

Immuno-Oncology vs. ALTAI Oncology ranking comparison

Compare Immuno-Oncology ranking trend in the past 28 days vs. ALTAI Oncology

Rank

No Data Available

Immuno-Oncology vs. ALTAI Oncology ranking by country comparison

Compare Immuno-Oncology ranking trend in the past 28 days vs. ALTAI Oncology

No Data to Display

Compare to any site with our free trial

Get started
Immuno-Oncology VS.
ALTAI Oncology

December 17, 2024